North America Patient-Controlled Analgesic Pumps Market By Type (Electronic and Mechanical), By Application (Oncology, Diabetes, Hematology, Gastroenterology and Others), By End-use (Hospitals, Specialty Clinics and Ambulatory Surgical Centers), By Country, Growth Potential, Industry Analysis Report and Forecast, 2021 - 2027
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the North America Patient-Controlled Analgesic Pumps Market
Market Report Description
The North America Patient-controlled Analgesic Pumps Market would witness market growth of 8.9% CAGR during the forecast period (2021-2027). A method where the patient in pain becomes empowered to relieve his/her own pain is termed as Patient-controlled analgesia (PCA).
Post-surgery, patients generally use computerized pump which is integrated in PCA. It often finds usage for post-operative management. With its pain-relief technique, patients become empowered to control their own pain. PCA acts as an ideal device for those patients who are having problems in consuming medication orally. Morphine, fentanyl and hydromorphone are some of the drugs given by PCA infusion.
Sometimes, the dose is predetermined and it is possible for the patients to deliver extra doses to themselves just by pressing a button. Parents as well as nurses can easily use this device for children of 6 years or below. Higher patient satisfaction, the superior quality of recovery, less sedation, a smaller number of postoperative complications, and fewer medications (as doses are set) are some of the major benefits of PCA. However, PCA also has some demerits including nurse assistance is needed when children are aged less than 5 years, chances of underdose or overdose of medication, difficulty to incorporate in patients having a critical illness (as it could result in nausea, itching, and constipation).
The US market dominated the North America Mechanical Market by Country in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $82,013.6 Thousands by 2027. The Canada market is experiencing a CAGR of 12.6% during (2021 - 2027). Additionally, The Mexico market would witness a CAGR of 11.6% during (2021 - 2027).
Based on Type, the market is segmented into Electronic and Mechanical. Based on Application, the market is segmented into Oncology, Diabetes, Hematology, Gastroenterology and Others. Based on End-use, the market is segmented into Hospitals, Specialty Clinics and Ambulatory Surgical Centers. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Smiths Group PLC, Fresenius SE & Co. KGaA, B. Braun Melsungen AG, Baxter International, Inc., Becton, Dickinson and Company, Terumo Corporation, Abbott Laboratories, Avante Health Solutions, ICU Medical, Inc., and Ace Medical Co., Ltd.
Scope of the Study
Market Segments Covered in the Report:
By End Use
- Specialty Clinics
- Ambulatory Surgical Centers
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Smiths Group PLC
- Fresenius SE & Co. KGaA
- B. Braun Melsungen AG
- Baxter International, Inc.
- Becton, Dickinson and Company
- Terumo Corporation
- Abbott Laboratories
- Avante Health Solutions
- ICU Medical, Inc.
- Ace Medical Co., Ltd.
Unique Offerings from KBV Research
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free